Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq:BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on January 11, 2024 of previously disclosed inducement equity awards to Robert (Rob) Claypoole in connection with this appointment as President and Chief Executive Officer, and Principle Executive Officer of the Company.
Related news for (BVS)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/06/25 06:00 PM
- MoBot’s Stock Market Highlights – 08/06/25 05:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/06/25 04:00 PM
- 24/7 Market News Snapshot 06 August, 2025 – Bioventus Inc. Class A Common Stock (NASDAQ:BVS)
- Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity